Nutriband Inc.

AI Score

0

Unlock

2.25
0.47 (26.40%)
At close: Feb 07, 2025, 2:33 PM
2.25
0.00%
After-hours Feb 07, 2025, 02:32 PM EST
undefined%
Bid 1.86
Market Cap 103.06M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.505
PE Ratio (ttm) -4.46
Forward PE n/a
Analyst n/a
Ask n/a
Volume 20,352
Avg. Volume (20D) 8,166
Open 2.08
Previous Close 1.78
Day's Range 1.77 - 2.53
52-Week Range 0.19 - 5.25
Beta undefined

About NTRBW

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated...

Industry Biotechnology
Sector Healthcare
IPO Date Oct 1, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol NTRBW
No News article available yet